-
David Moenning's Daily State of the Markets: 7/23
-
Notable Analyst Rating Changes 7/1: SIRI, AXP, NVDA, CTAS Upgraded; FO, ALTR, RBN Downgraded
-
David Moenning's Daily State of the Markets: 5/14
-
Wachovia raises its valuation range on Genzyme (GENZ) to $90-$95

